MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jso.26282

Медицинская библиотека · Journal of surgical oncology · 2020

Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis.

Ryon Emily L, Kronenfeld Joshua P, Lee Rachel M, Yopp Adam, Wang Annie, Lee Ann Y, Luu Sommer, Hsu Cary, Silberfein Eric, Russell Maria C, Goel Neha, Merchant Nipun B, Datta Jashodeep

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Although consensus guidelines generally discourage any surgical management (ASM; i.e., resection and/or transplantation) in patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT), recent series from Asia have challenged this paradigm.

METHODS

Patients from the US Safety Net Collaborative database (2012-2014) with localized HCC and radiographically confirmed PVT were propensity-score matched based on demographic and clinicopathologic factors associated with receipt of ASM and overall survival (OS). OS was compared between patients undergoing ASM and those not selected for surgery.

RESULTS

Of 1910 HCC patients, 207 (14.5%) had localized disease and PVT. The majority received either liver-directed therapies (LDTs; 34%) and/or targeted systemic therapies (36%). Twenty-one patients (10.1%) underwent ASM (resection [n = 11], transplantation [n = 10]); a third experienced any complication with no 30-day mortalities. Independent predictors of undergoing ASM were younger age, recent hepatology consultation, and lower model of end-stage liver disease (MELD) score. After matching for age, comorbidities, MELD, tumor size, receipt of LDT, or systemic therapy, OS was significantly longer for patients selected for ASM versus non-ASM patients (median not reached vs. 5.8 months, p < .001).

CONCLUSION

In a large North American multi-institutional cohort, a minority of HCC patients with PVT were selected for ASM. Resection or transplantation was associated with improved survival and may have a role in the multimodality management in selected patients.

Для цитирования: Ryon Emily L, Kronenfeld Joshua P, Lee Rachel M, Yopp Adam, Wang Annie, Lee Ann Y, Luu Sommer, Hsu Cary, Silberfein Eric, Russell Maria C, Goel Neha, Merchant Nipun B, Datta Jashodeep. Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis.. Journal of surgical oncology. 2020. DOI: 10.1002/jso.26282.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.